Approximately 1% of the tumor cells were S100+, CD34+, SOX10+, and MIB-1 positive, and the growth was diagnosed as a myxoid low-grade malignant peripheral nerve sheath tumor (MPNST). This evidence concerns the gene MIB1 and malignant peripheral nerve sheath tumor.